Recurrent bacterial meningitis by three different pathogens in an isolated asplenic child.

Authors:
Address: Department of Pediatrics, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe, 651-2273, Japan, s00-081@nms.ac.jp.
Journal:


Publication:

abstract

isolated congenital asplenia (ICA) is a rare condition at risk for overwhelming infection. When complicated by invasive infection, the mortality remains high, at greater than 60%. We describe a girl with ICA who developed Recurrent meningitis by three different pathogens. The first, meningitis by Escherichia coli, occurred 4 days after premature birth. The other two pathogens were serotype 6B Streptococcus pneumoniae and Haemophilus influenzae type b (Hib), at 18 and 25 months of age, respectively. The patient was successfully treated with prompt antimicrobial therapy in all episodes. Serum anti-polyribosylribitol phosphate (PRP) and anti-6B-type pneumococcal antibodies were below the levels for protective activity after natural infections. Although anti-PRP antibody was significantly increased after Hib vaccination, two (6B and 19F) of seven serotype-specific pneumococcal antibodies were not elevated to protective levels after the second 7-valent pneumococcal conjugate vaccine (PCV7). We, therefore, added a third PCV7. To our knowledge, this is the first neonatal ICA patient with invasive infection and the first case of bacterial meningitis occurring three times. Our findings indicate that monitoring of immune responses after natural infections and vaccinations, and reevaluations of vaccine schedule, are important for ICA patients to prevent subsequent invasive infections.



Related Articles
Immune response to pneumococcal conjugate vaccination in asplenic individuals.
Hum Vaccin. 2009
Immune response to pneumococcal conjugate vaccination in asplenic individuals.
Stanford E, Print F, Falconer M, Lamden K, Ghebrehewet S, Phin N, Baxter D, Helbert M, McCann R, Andrews N, et al. Hum Vaccin. 2009 Feb; 5(2):85-91. Epub 2009 Feb 7.
Invasive pneumococcal infections in children with asplenia.
Pediatr Infect Dis J. 2002
Invasive pneumococcal infections in children with asplenia.
Schutze GE, Mason EO Jr, Barson WJ, Kim KS, Wald ER, Givner LB, Tan TQ, Bradley JS, Yogev R, Kaplan SL. Pediatr Infect Dis J. 2002 Apr; 21(4):278-82.
Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
Pediatr Allergy Immunol. 1998
Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
Berthet F, Prehn A, Suter R, Ethevenaux C, Seger RA. Pediatr Allergy Immunol. 1998 Aug; 9(3):156-60.
Review Pneumococcal conjugate vaccine for young children.
Manag Care. 2000
Review Pneumococcal conjugate vaccine for young children.
Selman S, Hayes D, Perin LA, Hayes WS. Manag Care. 2000 Sep; 9(9):49-52, 54, 56-7 passim.
Review Bacterial meningitis: the impact of vaccination.
CNS Drugs. 2007
Review Bacterial meningitis: the impact of vaccination.
Makwana N, Riordan FA. CNS Drugs. 2007; 21(5):355-66.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.